KINS vs PFE · P/E 6.8, rev $214.9M vs P/E 20, rev $15.03B
Kingstone Companies Inc (KINS) versus Pfizer Inc (PFE) — a side-by-side from cached financials, not a winner call.
Kingstone Companies Inc (KINS) is a insurance - property & casualty company listed on US.
Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla.
Latest reported KINS revenue for 2025-12-31 was $214.9M. Net income was $40.8M. Revenue was up 38.5% from 2024-12-31 to 2025-12-31. KINS currently screens at market cap $217.9M and trailing P/E 6.8.
Latest reported PFE revenue for 2026-06-28 was $15.03B. Net income was -$248.0M. Revenue was up 4.0% from 2026-03-29 to 2026-06-28. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
KINS currently screens at market cap $217.9M and trailing P/E 6.8. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
Not investment advice. Open the KINS and PFE stock pages for the full models.
Not investment advice.